CHRNA7 and COVID-19: It has been posited that the use of non-invasive vagus nerve stimulation, which activates the anti-inflammatory α7nAChR-mediated response, may be a potential treatment strategy to decrease the hyper-inflammatory syndrome observed in COVID-19 [62,63].